miR-Rx16
N/A
Report date: 2022/02/08 09:33:06
NME
Base Information
Drug NamemiR-Rx16
Drug Alias Name +[18]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSynlogic IncThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSynlogic IncThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A